Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 3
2005 9
2006 4
2007 1
2008 5
2009 5
2010 5
2011 7
2012 10
2013 8
2014 6
2015 8
2016 7
2017 5
2018 11
2019 4
2020 4
2021 8
2022 11
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
Fischer L, Jiang L, Dürig J, Schmidt C, Stilgenbauer S, Bouabdallah K, Solal-Celigny P, Scholz CW, Feugier P, de Wit M, Trappe RU, Hallek M, Graeven U, Hänel M, Hoffmann M, Delwail V, Macro M, Greiner J, Giagounidis AAN, Dargel B, Durot E, Foussard C, Silkenstedt E, Weigert O, Pott C, Klapper W, Hiddemann W, Unterhalt M, Hoster E, Ribrag V, Dreyling M. Fischer L, et al. Among authors: scholz cw. Leukemia. 2024 Apr 27. doi: 10.1038/s41375-024-02254-2. Online ahead of print. Leukemia. 2024. PMID: 38678093
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Bittrich M, Kriegsmann K, Tietze-Stolley C, Movassaghi K, Grube M, Vucinic V, Wehler D, Burchert A, Schmidt-Hieber M, Rank A, Dürk HA, Metzner B, Kimmich C, Hentrich M, Kunz C, Hartmann F, Khandanpour C, de Wit M, Holtick U, Kiehl M, Stoltefuß A, Kiani A, Naumann R, Scholz CW, Tischler HJ, Görner M, Brand F, Ehmer M, Kröger N. Bittrich M, et al. Among authors: scholz cw. Transfus Med Hemother. 2023 Oct 16;50(6):475-490. doi: 10.1159/000531935. eCollection 2023 Dec. Transfus Med Hemother. 2023. PMID: 38089497 Free PMC article.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Kriegsmann K, Bittrich M, Sauer S, Tietze-Stolley C, Movassaghi K, Grube M, Vucinic V, Wehler D, Burchert A, Schmidt-Hieber M, Rank A, Dürk HA, Metzner B, Kimmich C, Hentrich M, Kunz C, Hartmann F, Khandanpour C, de Wit M, Holtick U, Kiehl M, Stoltefuß A, Kiani A, Naumann R, Scholz CW, Tischler HJ, Görner M, Brand F, Ehmer M, Kröger N. Kriegsmann K, et al. Among authors: scholz cw. Transfus Med Hemother. 2023 Sep 21;50(5):403-416. doi: 10.1159/000531936. eCollection 2023 Oct. Transfus Med Hemother. 2023. PMID: 37899991 Free PMC article.
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
Oerlemans S, Efficace F, Shamieh O, Cardoso Borges F, de Jong C, Dong D, Lehmann J, Malak S, Petranovic D, Scholz CW, Caocci G, Molica S, Griskevicius L, Nagele E, Bredart A, Carvalho E, Xochelli A, Agelink van Rentergem J, Alrjoob W, Mueller A, Freitas AC, Cocks K, Creutzberg C, Kyriakou C, van de Poll-Franse L. Oerlemans S, et al. Among authors: scholz cw. Blood Adv. 2023 Nov 28;7(22):7045-7055. doi: 10.1182/bloodadvances.2023010841. Blood Adv. 2023. PMID: 37738090 Free PMC article.
Dynamic interactome of the MHC I peptide loading complex in human dendritic cells.
Barends M, Koller N, Schölz C, Durán V, Bošnjak B, Becker J, Döring M, Blees H, Förster R, Kalinke U, Tampé R. Barends M, et al. Among authors: scholz c. Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2219790120. doi: 10.1073/pnas.2219790120. Epub 2023 Jun 12. Proc Natl Acad Sci U S A. 2023. PMID: 37307450 Free PMC article.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S, Efficace F, Kyriakou C, Freitas AC, Shamieh O, Creutzberg CL, Lehmann J, Petranovic D, Nagele E, Bredart A, Dong D, Scholz CW, Caocci G, Molica S, Griskevicius L, Xochelli A, Kieffer JM, Agelink van Rentergem JA, Alrjoub W, Mueller A, Gomes Da Silva M, Alves da Costa F, Malak S, Cocks K, van de Poll-Franse LV; EORTC Quality of Life Group. Oerlemans S, et al. Among authors: scholz cw. Cancer. 2023 Sep 1;129(17):2727-2740. doi: 10.1002/cncr.34822. Epub 2023 May 19. Cancer. 2023. PMID: 37204189
Raising Immunization Rates Among Cancer Patients.
Kiderlen TR, Trostdorf K, Delmastro N, Salomon A, Scholz CW, Späth-Schwalbe E, Mansmann V, Roll S, Reinwald M, Wit M. Kiderlen TR, et al. Among authors: scholz cw. Dtsch Arztebl Int. 2022 Jul 1;119(26):466-467. doi: 10.3238/arztebl.m2022.0167. Dtsch Arztebl Int. 2022. PMID: 36321685 Free PMC article. No abstract available.
126 results